thebell

전체기사

Krafton allots shares worth $970 mil to employees Portion unlikely to be fully subscribed

Translated by Kim So-in 공개 2021-06-23 08:02:46

이 기사는 2021년 06월 23일 07:54 thebell 에 표출된 기사입니다.

South Korea-based game publisher Krafton has set aside as much as 1.1 trillion won ($970 million) worth of shares for its employees as it prepares for an initial public offering (IPO), although the portion is unlikely to be fully subscribed given the size of the allotment per person.

Krafton said in a prospectus it allotted some two million shares, or 20% of the total shares offered in the IPO, to its employees based on local capital market regulations. The employee portion could be worth between 921.5 billion won and 1.12 trillion won based on the proposed price band of 458,000 won and 557,000 won.

It is the largest amount among multi-trillion IPO deals so far this year as the Krafton’s mega IPO is likely to be the nation’s largest ever. In the IPO of SK Bioscience, the employee quota was worth 298.3 billion won based on the upper end of the price range, while SK IE Technology (SKIET) set aside 449.1 billion won worth of shares for its employees.

SK Bioscience’s employee quota was undersubscribed by around 7 billion won and SKIET’s employee portion was undersubscribed by 152.6 billion won despite the relatively small per-person size of the portion compared to the Krafton deal.

SK Bioscience had 591 employees, with an average allocation of 500 million won per person while SKIET had 218 employees, which translates into an average allocation of 2 billion won per person. SKIET allocated 1.3 billion won per person on average.

Krafton has a total of 1330 employees, of which 1264 are full-time employees. Assuming that the price is set at the upper end of the range and only full-time employees participate, then the employee quota will be around 880 million won per person on average.

Krafton's estimated average per-person allocation is about 500 million won smaller than SKIET’s 1.3 billion won and 300 million won larger than SK Bioscience's 500 million won. Unsubscribed shares in the employee portion can be purchased by ordinary retail investors, which can buy up to 30% of the total shares offered in the IPO. (Reporting by Kyung-ju Lee)
< 저작권자 ⓒ 자본시장 미디어 'thebell', 무단 전재, 재배포 및 AI학습 이용 금지 >
주)더벨 주소서울시 종로구 청계천로 41 영풍빌딩 5층, 6층대표/발행인성화용 편집인이진우 등록번호서울아00483
등록년월일2007.12.27 / 제호 : 더벨(thebell) 발행년월일2007.12.30청소년보호관리책임자김용관
문의TEL : 02-724-4100 / FAX : 02-724-4109서비스 문의 및 PC 초기화TEL : 02-724-4102기술 및 장애문의TEL : 02-724-4159

더벨의 모든 기사(콘텐트)는 저작권법의 보호를 받으며, 무단 전재 및 복사와 배포 등을 금지합니다.

copyright ⓒ thebell all rights reserved.